Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[For patients with no evidence of disease and a follow-up of at least 5 years, the mean percent MIB-1 value was significantly lower than for those patients who were alive with local recurrence and/or metastasis or who had died from their adenoid cystic carcinoma (p =.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP930410.RAnRj9CoMRkHtwpezKP-JaRJMPnffe5DbzTN4V2KcT6bg130_assertion description "[For patients with no evidence of disease and a follow-up of at least 5 years, the mean percent MIB-1 value was significantly lower than for those patients who were alive with local recurrence and/or metastasis or who had died from their adenoid cystic carcinoma (p =.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP930410.RAnRj9CoMRkHtwpezKP-JaRJMPnffe5DbzTN4V2KcT6bg130_provenance.
• NP361694.RA_Eu37I1ALckTkABJQR1F1jPonCHVkHL1y46hZ_kmftM130_assertion description "[For patients with no evidence of disease and a follow-up of at least 5 years, the mean percent MIB-1 value was significantly lower than for those patients who were alive with local recurrence and/or metastasis or who had died from their adenoid cystic carcinoma (p =.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP361694.RA_Eu37I1ALckTkABJQR1F1jPonCHVkHL1y46hZ_kmftM130_provenance.
• NP208199.RAYgXojJh-2B13ijLOa0QBbs8DCWnu79gl3i3kHzAP_3I130_assertion description "[For patients with no evidence of disease and a follow-up of at least 5 years, the mean percent MIB-1 value was significantly lower than for those patients who were alive with local recurrence and/or metastasis or who had died from their adenoid cystic carcinoma (p =.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP208199.RAYgXojJh-2B13ijLOa0QBbs8DCWnu79gl3i3kHzAP_3I130_provenance.
• NP862337.RAZy0wUdnP7mFB9mQog2G6ITGBU2Wvg2J37pr5kU75u1c130_assertion description "[For patients with no evidence of disease and a follow-up of at least 5 years, the mean percent MIB-1 value was significantly lower than for those patients who were alive with local recurrence and/or metastasis or who had died from their adenoid cystic carcinoma (p =.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP862337.RAZy0wUdnP7mFB9mQog2G6ITGBU2Wvg2J37pr5kU75u1c130_provenance.
• NP850807.RA-16eN8CyOlRj6SBqD1AJJeI76eOXjptbzJ5d7z0YX1Y130_assertion description "[For patients with no evidence of disease and a follow-up of at least 5 years, the mean percent MIB-1 value was significantly lower than for those patients who were alive with local recurrence and/or metastasis or who had died from their adenoid cystic carcinoma (p =.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP850807.RA-16eN8CyOlRj6SBqD1AJJeI76eOXjptbzJ5d7z0YX1Y130_provenance.
• NP931297.RAeWg9Q6RuDNLYhwzUQPJ0TjqrGkeXd2B1WkvjfQMhwek130_assertion description "[For patients with no evidence of disease and a follow-up of at least 5 years, the mean percent MIB-1 value was significantly lower than for those patients who were alive with local recurrence and/or metastasis or who had died from their adenoid cystic carcinoma (p =.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931297.RAeWg9Q6RuDNLYhwzUQPJ0TjqrGkeXd2B1WkvjfQMhwek130_provenance.
• NP931356.RAZoPBog47nlFihjxCfXZCfFs-Cq-FUraK_bpPRSjlb6g130_assertion description "[For patients with no evidence of disease and a follow-up of at least 5 years, the mean percent MIB-1 value was significantly lower than for those patients who were alive with local recurrence and/or metastasis or who had died from their adenoid cystic carcinoma (p =.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931356.RAZoPBog47nlFihjxCfXZCfFs-Cq-FUraK_bpPRSjlb6g130_provenance.
• NP931531.RAVtMdKu26qylTC38clNEZTtfYuXJpwuGyeqHf2gw01nI130_assertion description "[For patients with no evidence of disease and a follow-up of at least 5 years, the mean percent MIB-1 value was significantly lower than for those patients who were alive with local recurrence and/or metastasis or who had died from their adenoid cystic carcinoma (p =.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931531.RAVtMdKu26qylTC38clNEZTtfYuXJpwuGyeqHf2gw01nI130_provenance.
• NP791336.RANT_TlARp0Fc5TTPCt5_iGd2bYJ2FPJl_UmTRUmmLva0130_assertion description "[For patients with no evidence of disease and a follow-up of at least 5 years, the mean percent MIB-1 value was significantly lower than for those patients who were alive with local recurrence and/or metastasis or who had died from their adenoid cystic carcinoma (p =.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP791336.RANT_TlARp0Fc5TTPCt5_iGd2bYJ2FPJl_UmTRUmmLva0130_provenance.
• NP289219.RAAbbzh2a_EGBdqp3hJHP_FMNkJYFxDu7mznmL6QvxsLk130_assertion description "[For patients with no evidence of disease and a follow-up of at least 5 years, the mean percent MIB-1 value was significantly lower than for those patients who were alive with local recurrence and/or metastasis or who had died from their adenoid cystic carcinoma (p =.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP289219.RAAbbzh2a_EGBdqp3hJHP_FMNkJYFxDu7mznmL6QvxsLk130_provenance.
• NP557603.RAozwqsGikXPud0xPckaQ4xF9kc1odvXyzJQVH8M0G7pY130_assertion description "[For patients with no evidence of disease and a follow-up of at least 5 years, the mean percent MIB-1 value was significantly lower than for those patients who were alive with local recurrence and/or metastasis or who had died from their adenoid cystic carcinoma (p =.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557603.RAozwqsGikXPud0xPckaQ4xF9kc1odvXyzJQVH8M0G7pY130_provenance.
• NP557820.RAhDxvdKoS1tieUuvsC3o4FFsTBQgs1OO1QpN8JAZuMgU130_assertion description "[For patients with no evidence of disease and a follow-up of at least 5 years, the mean percent MIB-1 value was significantly lower than for those patients who were alive with local recurrence and/or metastasis or who had died from their adenoid cystic carcinoma (p =.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557820.RAhDxvdKoS1tieUuvsC3o4FFsTBQgs1OO1QpN8JAZuMgU130_provenance.
• NP289220.RAbWkHkrXfzIrGjdQQPveXAUszy9q5BzeEMmB_xFl72pc130_assertion description "[For patients with no evidence of disease and a follow-up of at least 5 years, the mean percent MIB-1 value was significantly lower than for those patients who were alive with local recurrence and/or metastasis or who had died from their adenoid cystic carcinoma (p =.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP289220.RAbWkHkrXfzIrGjdQQPveXAUszy9q5BzeEMmB_xFl72pc130_provenance.
• NP931561.RADW7qu0Ey1JGjO4gAY0QGRfeLssDGhd0MbTjtDVecu-c130_assertion description "[For patients with no evidence of disease and a follow-up of at least 5 years, the mean percent MIB-1 value was significantly lower than for those patients who were alive with local recurrence and/or metastasis or who had died from their adenoid cystic carcinoma (p =.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931561.RADW7qu0Ey1JGjO4gAY0QGRfeLssDGhd0MbTjtDVecu-c130_provenance.
• NP289222.RAp9AapqsMoh0iexpVY7sKOn20xYnSDNaZUaURcg8TCcw130_assertion description "[For patients with no evidence of disease and a follow-up of at least 5 years, the mean percent MIB-1 value was significantly lower than for those patients who were alive with local recurrence and/or metastasis or who had died from their adenoid cystic carcinoma (p =.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP289222.RAp9AapqsMoh0iexpVY7sKOn20xYnSDNaZUaURcg8TCcw130_provenance.
• NP557659.RAL2l33fKrQgNKkE4jBcG1WpobgJ8zUbWaBYu-xEMf0nY130_assertion description "[For patients with no evidence of disease and a follow-up of at least 5 years, the mean percent MIB-1 value was significantly lower than for those patients who were alive with local recurrence and/or metastasis or who had died from their adenoid cystic carcinoma (p =.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557659.RAL2l33fKrQgNKkE4jBcG1WpobgJ8zUbWaBYu-xEMf0nY130_provenance.
• NP557847.RANEyVsJAC9FTyW9z0306Q31ymQutqwRD2iIo8dReq3i0130_assertion description "[For patients with no evidence of disease and a follow-up of at least 5 years, the mean percent MIB-1 value was significantly lower than for those patients who were alive with local recurrence and/or metastasis or who had died from their adenoid cystic carcinoma (p =.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557847.RANEyVsJAC9FTyW9z0306Q31ymQutqwRD2iIo8dReq3i0130_provenance.
• NP289221.RAzq84PFARdg32PMAIKYS14iRJswzjmZoTCAbqUZzd0kA130_assertion description "[For patients with no evidence of disease and a follow-up of at least 5 years, the mean percent MIB-1 value was significantly lower than for those patients who were alive with local recurrence and/or metastasis or who had died from their adenoid cystic carcinoma (p =.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP289221.RAzq84PFARdg32PMAIKYS14iRJswzjmZoTCAbqUZzd0kA130_provenance.